<DOC>
	<DOCNO>NCT02261402</DOCNO>
	<brief_summary>`` Medisinstart '' new service develop use Norwegian pharmacy . It intend patient start new medicine chronic long-term condition . It base research show problem newly prescribe medicine appear rapidly significant portion patient quickly become non-adherent . The service consist two follow-up consultation pharmacist . The first 1-2 week second 3-5 week start new medicine . The main purpose study investigate whether `` Medisinstart '' increase patient ' adherence prescribe medication . Patients ' belief medicine motivation adherence also examine . The study also aim reveal `` Medisinstart '' additional benefit patient , society pharmacy .</brief_summary>
	<brief_title>Effectiveness `` Medisinstart ''</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>First time prescription drug belong one follow group ( ATCcode ) : Dabigatran etexilate ( B01AE07 ) Rivaroxaban ( B01AF01 ) Apixaban ( B01AF02 ) Beta block agent ( C07 ) Calcium channel blocker ( C08 ) Agents act reninangiotensin system ( C09 ) HMG CoA reductase inhibitor ( statin ) ( C10AA ) Prior use ( within last 3 year ) drug question independent strength , dose formulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Adherence</keyword>
	<keyword>Morisky Medication Adherence Scale</keyword>
	<keyword>Beliefs Medicines Questionnaire</keyword>
	<keyword>Medication Possession Ratio</keyword>
	<keyword>Medication-Related Problems</keyword>
	<keyword>Pharmacist</keyword>
	<keyword>Pharmacist Intervention</keyword>
	<keyword>Pharmacy</keyword>
	<keyword>Pharmacy Service</keyword>
	<keyword>Pharmacy Practice</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Antihypertensive Agents</keyword>
	<keyword>Anticoagulants</keyword>
	<keyword>Statins</keyword>
	<keyword>Dyslipidemia</keyword>
</DOC>